what is xyntha?
XYNTHA is a recombinant coagulation factor VIII product. It is used for the prevention and treatment of bleeding in adults, children and infants with haemophilia A.
How it works.
XYNTHA works by increasing the level of factor VIII in the blood so it can clot.
XYNTHA is a recombinant product.
Recombinant products are created in a laboratory using DNA technology.
Using the factor VIII gene, scientists can grow factor VIII in a non-human cell culture.
Factor VIII is then removed from the culture and purified using a high-tech process.
This process is designed to reduce the risk of viral contamination.
XYNTHA is made using a purification system.
Steps in the manufacturing and purification process designed to reduce the risk of viral contamination.
Factor VIII is grown in an albumin-free cell culture (i.e. no added human or animal material).
The solution is then purified to inactivate potential viruses.
A man-made molecule (synthetic ligand) is used to catch and hold XYNTHA so it can be collected and cleansed.
XYNTHA then goes through a tiny filter (nanofiltration) to further safeguard against potential viruses.